Cancer Research UK’s Commercial Partnerships team, a component of the Research and Innovation division, develops promising ideas into successful cancer therapeutics, vaccines, diagnostics and enabling technologies.
Our partnerships are many and varied - Cancer Research UK has built an extensive pipeline of partnered projects, created a number of successful multi-project drug discovery alliances and built more than 35 spin out companies. We have a proven track record in delivering drugs to the clinic and the market and provide commercialisation services to oncology institutes worldwide.
Our Business Development Managers help researchers identify and develop their most commercially and clinically promising projects.
Our flexible approach to commercialisation enables us to work with a diverse range of commercial and academic organisations.
We aim to bring breakthrough therapeutics to cancer patients sooner through initiatives such as Clinical Development Partnerships.
We've expanded our licensing portfolio in imaging and diagnostics, one of the most effective means of detecting cancer.
We can propel promising research to the next stage by helping scientists access appropriate translational funding and in-kind support.